Dendritic Cell Vaccine for Patients With Brain Tumors

NCT01204684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Anaplastic Astrocytoma
Anaplastic Astro-oligodendroglioma
Glioblastoma

Interventions

BIOLOGICAL: autologous tumor lysate-pulsed DC vaccination
BIOLOGICAL: Tumor lysate-pulsed DC vaccination+0.2% resiquimod
BIOLOGICAL: Tumor-lysate pulsed DC vaccination +adjuvant polyICLC

Sponsor

Jonsson Comprehensive Cancer Center